EnWave Appoints New Executive Chairman, Announces Change in Management, Private Placement with Director and Grants Stock Opti...

EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave", or the "Company")
is pleased to announce the appointment of Mr. John P.A. Budreski as a Director
and Executive Chairman of the Board of EnWave. 


Mr. Budreski joins EnWave with over 30 years of extensive capital markets and
executive management experience. Mr. Budreski has a professional history of
advancing and accelerating businesses, as well as tangible engineering
experience. He was formerly a Vice Chairman of Cormark Securities Inc. from 2009
to 2012 and President and CEO of Orion Securities Inc. from 2005 to 2007, prior
to its successful sale to Macquarie Bank. He has filled the roles of a Managing
Director of Equity Capital Markets and Head of Investment Banking for Scotia
Capital Inc. from March 1998 to February 2005 after starting out as a Managing
Director of US Institutional Equity Group for Scotia Capital. He also held
senior roles in investment banking and equity sales and trading for RBC Dominion
Securities. Mr. Budreski is currently a Director of Sandstorm Gold Ltd., Alaris
Royalty Corporation and Delta Gold Corporation. He is also the Chief Executive
Officer and a Director of Morien Resources Corporation. He holds a Bachelor of
Engineering from Dalhousie / TUNS University and an MBA from the University of
Calgary.


With Mr. Budreski's appointment, Dr. Tim Durance will become the sole President
and Chief Executive Officer of the Company and vacate the position of Chairman
on the Board of Directors. The Company also announces that, effective June 30th,
2014, Mr. John McNicol, who served as the Company's President, co-CEO and as a
Director on the Board from February 2007 until June 2014, will be reducing his
role with EnWave to become a Consultant, enabling him to pursue personal
interests.


"EnWave's management is very pleased to have such a qualified business
professional join the executive team, especially at a time when the Company's
Radiant Energy Vacuum ("REV(TM)") technology is experiencing a commercialization
inflection point," stated Dr. Tim Durance, President & CEO of EnWave. "On behalf
of the EnWave Board and management team I would also like to thank John McNicol
for his valued contributions to the development of EnWave over the past seven
years." 


Additionally, EnWave announces that it has granted a total of 800,000 stock
options to Mr. Budreski pursuant to its Share Option Plan (the "Plan"). Each
option will entitle Mr. Budreski to purchase one common share of the Company at
an exercise price of $1.35 per share for a period of five years from this date.
The options will vest in accordance to provisions set out in the Plan, or as
otherwise required by the TSX Venture Exchange. The grant is subject to
regulatory approval.


The stock options granted to Mr. Budreski are part of his compensation package
and will provide him with an opportunity to establish a meaningful position in
EnWave as the Company continues to progress. 


Lastly, the Company announces that it has agreed to a private placement (the
"Private Placement") with Mr. Budreski, who will be adding to his existing
holdings of EnWave through the purchase of 111,111 common shares at price of
$1.35 per share, for cash proceeds to the Company of $150,000. 


The net proceeds from the Private Placement shall be used for working capital
and general corporate purposes.


The common shares of Enwave to be issued in connection with the Private
Placement will be subject to a statutory four-month hold period. Completion of
the Private Placement is subject to a number of conditions, including, without
limitation, the receipt of all required regulatory approvals, including approval
of the TSX Venture Exchange.


About EnWave 

EnWave Corporation is a Vancouver-based industrial technology company developing
commercial applications for its proprietary Radiant Energy Vacuum (REV(TM))
dehydration technology. EnWave aims to sign royalty-bearing commercial licenses
with leading food and pharmaceutical companies for the use of its revolutionary
technology. Thus far the Company has signed ten royalty-bearing licenses,
opening up eight distinct market sectors for commercialization with companies
that include Bonduelle, a global leader in the production of vegetables; Hormel
Foods Corporation, a major processed meat manufacturer in the United States of
America; and Sutro Biopharma, a company developing a protein synthesis process
for the pharmaceutical industry. In addition to these licenses, EnWave has
formed a Limited Liability Partnership, NutraDried LLP, to develop, manufacture,
market and sell all-natural cheese snack products in the United States under the
Moon Cheese(R) brand. The Company has also signed a license and manufacturing
agreement with NutraDried Creations to market the dried cheese and other REV(TM)
snack products through private label distribution channels in the United States
and Latin America.


EnWave has signed a wide range of research agreements with an expanding list of
companies that include Nestle, Kellogg's, Ocean Spray Cranberries, Sun-Maid
Growers, R.J. Reynolds and Merck among others. EnWave is introducing REV(TM) as
a new dehydration standard in the food and biological material sectors:
potentially faster and cheaper than freeze drying, with better end product
quality than air drying or spray drying.


EnWave currently has six REV(TM) platforms: commercial-scale nutraREV(R) and
MIVAP(R) are used in the food industry to dry food products quickly and at
low-cost, while maintaining high levels of nutrition, taste, texture and colour.
The Company has also commercialized powderREV(R) for bulk dehydration of food
cultures, probiotics and fine biochemicals such as enzymes below the freezing
point; quantaREV(TM) for continuous, high-volume low-temperature drying; and
bioREV(TM) and freezeREV(TM) as new methods to stabilize and dehydrate
biopharmaceuticals such as vaccines and antibodies. More information about
EnWave is available at www.enwave.net. 




EnWave Corporation                                                          
Dr. Tim Durance                                                             
President, CEO & Director                                                   



Safe Harbour for Forward-Looking Information Statements: This press release may
contain forward-looking information based on management's expectations,
estimates and projections. All statements that address expectations or
projections about the future, including statements about the Company's strategy
for growth, product development, market position, expected expenditures, and the
Private Placement are forward-looking statements. These statements are not a
guarantee of future performance and involve a number of risks, uncertainties and
assumptions. Although the Company has attempted to identify important factors
that could cause actual results to differ materially, there may be other factors
that cause results not to be as anticipated, estimated or intended. There can be
no assurance that such statements will prove to be accurate, as actual results
and future events could differ materially from those anticipated in such
statements. Accordingly, readers should not place undue reliance on
forward-looking statements.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Mr. John Budreski
Executive Chairman
EnWave Corporation
([phone]
E-mail: [e-mail]


Mr. Brent Charleton
Vice President, Corporate Affairs
([phone]
E-mail: [e-mail]